ALANTOS PHARMACEUTICALS INC has a total of 31 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are SITEONE THERAPEUTICS INC, ALANTOS PHARM HOLDING and DEVITA ROBERT J.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 4 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | United States | 4 | |
#6 | China | 3 | |
#7 | Argentina | 1 | |
#8 | Costa Rica | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 | |
#12 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bluhm Harald | 23 |
#2 | Wu Xinyuan | 23 |
#3 | Deng Hongbo | 23 |
#4 | Sucholeiki Irving | 22 |
#5 | Taveras Arthur G | 21 |
#6 | Richter Frank | 20 |
#7 | Steeneck Christoph | 20 |
#8 | Gege Christian | 19 |
#9 | Hochguertel Matthias | 18 |
#10 | Van Veldhuizen Joshua | 16 |
Publication | Filing date | Title |
---|---|---|
US2007155738A1 | Heterobicyclic metalloprotease inhibitors | |
US2007155737A1 | Heterobicyclic metalloprotease inhibitors | |
CN101238127A | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors | |
CN101137414A | Multicyclic bis-amide mmp inhibitors | |
US2006173183A1 | Multicyclic bis-amide MMP inhibitors |